What is the current stock price of Kalaris Therapeutics Inc (KLRS)?

As of the latest market data, Kalaris Therapeutics Inc (KLRS) is trading at $6.30. The stock has seen a gain of 3.79% today.

Does Kalaris Therapeutics Inc (KLRS) pay a dividend?

Based on current data, Kalaris Therapeutics Inc does not have a confirmed active dividend policy.

What is the market cap of Kalaris Therapeutics Inc?

The current market capitalization of Kalaris Therapeutics Inc (KLRS) is approximately unavailable.

KLRS

Kalaris Therapeutics Inc·Healthcare

6.30

3.789%(+0.23)

Market Closed

8.00

26.984%(+1.70)

After Hours

Last Updated: — ET

52W L: $2.1452W H: $11.88

KLRS NEWS

globenewswire.com

Mar 17

Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates

Positive initial data reported from Phase 1a Single Ascending Dose study in nAMD in December 2025; preliminary data from ongoing Phase 1b/2 study expected in 1H 2027

defenseworld.net

Feb 18

Kalaris Therapeutics (NASDAQ:KLRS) Director Srinivas Akkaraju Buys 479,847 Shares of Stock

Kalaris Therapeutics Inc. (NASDAQ: KLRS - Get Free Report) Director Srinivas Akkaraju purchased 479,847 shares of the business's stock in a transaction on Thursday, December 18th. The shares were acquired at an average price of $10.42 per share, with a total value of $5,000,005.74. Following the completion of the transaction, the director owned 1,979,847 shares of

Company Profile

Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2020-07-30

Beta

0.18

Websitekalaristx.com↗